We demonstrated that NAFLD and NASH provoke different grades of brain dysfunction, which are characterized by the altered expression of BA receptors, FXR and TGR5, and activation of microglia. Here, GPBAR1 is linked to metabolic dysfunction-associated steatohepatitis.